Suchen Sie nach Informationen zu Hauptsitz Von Cubist Pharmaceuticals? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://en.wikipedia.org/wiki/Cubist_Pharmaceuticals#:~:text=Cubist%20Pharmaceuticals%20was%20an%20American%20biopharmaceutical%20company%20that,company%20employed%20638%20people%2C%20mostly%20in%20Lexington%2C%20MA.
https://en.wikipedia.org/wiki/Cubist_Pharmaceuticals
https://www.crunchbase.com/organization/cubist-pharmaceuticals
Phone Number 7812401261. Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called …
https://www.dnb.com/business-directory/company-profiles.cubist_pharmaceuticals_llc.29d7edcce4320c0c7a4af71a25f3f96d.html
Pharmaceutical and Medicine Manufacturing Chemical Manufacturing Manufacturing. Printer Friendly View. Address: 2000 Galloping Hill Rd Kenilworth, NJ, 07033-1310 United States See other locations. Phone: ?
https://opencorporates.com/companies/us_ca/201531010084
Free and open company data on California (US) company CUBIST PHARMACEUTICALS LLC (company number 201531010084), WEYSTRASSE 20 6000 LUCERNE 6 SWITZERLAND. Learn how to leverage transparent company data at scale. Subscribe to our emails. The Open Database Of The Corporate World. Search.
https://rocketreach.co/cubist-pharmaceuticals-profile_b5c62b53f42e0ca1
Cubist Pharmaceuticals Information. Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Acute care is the space where we work and invest. In the U.S., Cubist markets CUBICIN® (daptomycin for …
https://pitchbook.com/profiles/company/41218-57
Description. Researcher and developer of novel acute care therapies for use in hospitals and other acute care environments. The company works and invest in Acute care. In the U.S., Cubist markets CUBICIN® (daptomycin for injection), the first antibiotic in a class of anti-infectives called lipopeptides and ENTEREG® (alvimopan), the FDA-approved therapy to accelerate the time to …
https://www.linkedin.com/company/cubist-pharmaceuticals
Cubist Pharmaceuticals | 14,986 followers on LinkedIn. Effective January 22, 2015, Cubist Pharmaceuticals is now a wholly owned subsidiary of Merck & …
https://www.sbir.gov/sbc/cubist-pharmaceuticals-inc
DESCRIPTION (provided by applicant): The antibiotic daptomycin is produced by the Gram-positive bacterium Streptomyces roseosporus and is the first in a new class of investigational drugs called lipo ...
https://www.drugs.com/manufacturer/cubist-pharmaceuticals-inc-511.html
Cubist Pharmaceuticals, Inc. Cubist Pharmaceuticals, Inc. is now part of Merck & Co., Inc. (January 2015) See: Merck. Drugs.com Mobile Apps. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices. Explore Apps.
https://www.merck.com/news/merck-to-acquire-cubist-pharmaceuticals-for-102-per-share-in-cash/
will acquire Cubist for $102 per share in cash, which represents a 35. percent premium to Cubist’s average stock price for the most recent five. trading days. Unanimously approved by the boards of directors of both companies, the. transaction has an equity valuation of $8.4 billion and will also.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Cubist Pharmaceuticals gefunden haben.
